Hearing: “Unsustainable Drug Prices: Testimony from the CEOs (Part I and Part II)”

Committee on Oversight and Reform

Wednesday, September 30, 2020 (10:00 AM)

2154 RHOB
Washington, D.C.
This is a two part hearing on Sept. 30th and Oct. 1st, both starting at 10am. This is a hybrid in person/remote hearing.

Witnesses

Mr. Mark Alles
Former Chairman of the Board and Chief Executive Officer, Celgene Corporation

Added 09/28/2020 at 01:44 PM
  • Witness Statement [PDF] Added 09/30/2020 at 03:12 PM

Dr. Giovanni Caforio
Chairman of the Board and Chief Executive Officer, Bristol Myers Squibb Company

Added 09/28/2020 at 01:44 PM
  • Witness Statement [PDF] Added 09/30/2020 at 03:12 PM

Mr. Kare Schultz
President and Chief Executive Officer, Teva Pharmaceutical Industries Ltd.

Added 09/28/2020 at 01:44 PM
  • Witness Statement [PDF] Added 09/30/2020 at 03:12 PM

Support Documents

  • Notice [PDF] Added 09/22/2020 at 09:29 AM
  • Memo [PDF] Added 09/25/2020 at 03:58 PM

Hearing Record

  • Attendance [PDF] Added 09/30/2020 at 02:21 PM

First Published: September 22, 2020 at 09:28 AM
Last Updated: September 30, 2020 at 03:12 PM